Guardion Health Sciences, Inc. Common Stock

The global medical nutrition market is projected to grow significantly, driven by rising awareness of the importance of nutrition in disease management and prevention, as well as increasing diagnoses of chronic conditions like gastrointestinal disorders and diabetes. The demand for personalized nutritional solutions is fueling innovation and industry expansion.

Related tickers: NSRGY, GSK, SNY, ABT, DANOY, BASFY, FSNUY, GHSI, BAX.

Guardion Health Sciences announced its financial results for the three and six months ended June 30, 2024. The company completed the sale of its Viactiv brand and business, and its stockholders approved a plan of liquidation and dissolution. The company is reviewing alternative transaction proposals and expects to make a decision on cash distributions to stockholders in the coming quarter.

Related tickers: GHSI.